Non classé - Weezion

RICAI

François Vandenesch was invited to the 45th RICAI to present the outstanding results from patient tests.

EIC Seal of Excellence

Weezion has been awarded the Seal of Excellence

What would the World be without antibiotics?

In this article by the BBC, the fear of a world without efficient antibiotics is becoming a reality…

Weezion announces capital investment from bioMérieux

As part of a first round of funding, Weezion SAS announced today that it has secured a 2-million-euro investment from bioMérieux.

Born from a cutting-edge scientific collaboration between leading research institutes in Lyon -the Institute of Infectious Agents, the Institute of Analytical Sciences, and the International Center for Infectious Disease Research at Claude Bernard Lyon I University.

Weezion SAS is at the forefront of innovation in infectious disease diagnostics. Leveraging breakthrough research from the IdBIORIV project, Weezion transforms advanced hospital-university findings into market-ready, highly accurate in vitro diagnostic solutions for detecting microbial infections in the blood.